There is no field of medicine in which advances in therapy have been s o closely linked to a better understanding of molecular medicine than in the area of hematologic malignancies. Diagnostic and Therapeutic Ad vances in Hematologic Malignancies will provide practitioners and acad emic clinicians with a better understanding of the constantly evolving concepts in this area.